Vlot MC - Search Results

1

Bone geometry and trabecular bone score in transgender people before and after short- and long-term hormonal treatment.

Wiepjes CM, Vlot MC, de Blok CJM, Nota NM, de Jongh RT, den Heijer M. Wiepjes CM, et al. Among authors: vlot mc. Bone. 2019 Oct;127:280-286. doi: 10.1016/j.bone.2019.06.029. Epub 2019 Jul 1. Bone. 2019. PMID: 31271934

2

Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.

Vlot MC, Klink DT, den Heijer M, Blankenstein MA, Rotteveel J, Heijboer AC. Vlot MC, et al. Bone. 2017 Feb;95:11-19. doi: 10.1016/j.bone.2016.11.008. Epub 2016 Nov 11. Bone. 2017. PMID: 27845262 Clinical Trial.

3

Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.

Wiepjes CM, Vlot MC, Klaver M, Nota NM, de Blok CJ, de Jongh RT, Lips P, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M. Wiepjes CM, et al. Among authors: vlot mc. J Bone Miner Res. 2017 Jun;32(6):1252-1260. doi: 10.1002/jbmr.3102. Epub 2017 May 2. J Bone Miner Res. 2017. PMID: 28370342 Free article.

4

Plasma FGF23 is not elevated in prostate cancer.

Vlot MC, Bijnsdorp I, den Heijer M, de Jonge R, van Moorselaar RJA, Heijboer AC. Vlot MC, et al. Clin Chim Acta. 2018 Mar;478:129-131. doi: 10.1016/j.cca.2017.12.035. Epub 2017 Dec 23. Clin Chim Acta. 2018. PMID: 29277536 No abstract available.

5

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.

Vlot MC, Grijsen ML, Prins JM, de Jongh RT, de Jonge R, den Heijer M, Heijboer AC. Vlot MC, et al. PLoS One. 2018 Mar 9;13(3):e0193679. doi: 10.1371/journal.pone.0193679. eCollection 2018. PLoS One. 2018. PMID: 29522570 Free PMC article.

6

Clinical utility of bone markers in various diseases.

Vlot MC, den Heijer M, de Jongh RT, Vervloet MG, Lems WF, de Jonge R, Obermayer-Pietsch B, Heijboer AC. Vlot MC, et al. Bone. 2018 Sep;114:215-225. doi: 10.1016/j.bone.2018.06.011. Epub 2018 Jun 18. Bone. 2018. PMID: 29920402 Review.

7

Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.

Wiepjes CM, de Jongh RT, de Blok CJ, Vlot MC, Lips P, Twisk JW, den Heijer M. Wiepjes CM, et al. Among authors: vlot mc. J Bone Miner Res. 2019 Mar;34(3):447-454. doi: 10.1002/jbmr.3612. Epub 2018 Dec 7. J Bone Miner Res. 2019. PMID: 30537188 Free PMC article.

8

Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.

Vlot MC, Wiepjes CM, de Jongh RT, T'Sjoen G, Heijboer AC, den Heijer M. Vlot MC, et al. J Bone Miner Res. 2019 Oct;34(10):1862-1872. doi: 10.1002/jbmr.3762. Epub 2019 Aug 19. J Bone Miner Res. 2019. PMID: 31099910 Free PMC article. Clinical Trial.

9

Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort Study.

Wiepjes CM, de Blok CJ, Staphorsius AS, Nota NM, Vlot MC, de Jongh RT, den Heijer M. Wiepjes CM, et al. Among authors: vlot mc. J Bone Miner Res. 2020 Jan;35(1):64-70. doi: 10.1002/jbmr.3862. Epub 2019 Oct 7. J Bone Miner Res. 2020. PMID: 31487065 Free PMC article.

10

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations.

Vlot MC, Boekel L, Kragt J, Killestein J, van Amerongen BM, de Jonge R, den Heijer M, Heijboer AC. Vlot MC, et al. Nutrients. 2019 Nov 15;11(11):2774. doi: 10.3390/nu11112774. Nutrients. 2019. PMID: 31731605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters